BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Bay

  FDA Clears Expanded Claims for ‘Superbug’ Test

  Xpert® Carba-R now FDA-cleared to aid clinicians in determining appropriate therapeutic strategy for pure colony specimens

  May 15, 2018

   · 

  2 min read
• Drug Development

  Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update

  Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) (“Intec” or “the Company”) today announces financial results for the three months ended March 31, 2018 and provides a corporate update.

  May 15, 2018

   · 

  8 min read
• Business

  CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results

  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), today reported financial results for the first quarter and provided a review of recent accomplishments and anticipated upcoming milestones.

  May 15, 2018

   · 

  8 min read
• Business

  Cronos Group Inc. Announces First Quarter 2018 Results

  Q1 2018 total sales of $2.9 million, up 473% year over year

  May 15, 2018

   · 

  5 min read
• Business

  Concordia International Corp. Announces First Quarter 2018 Results

  First quarter 2018 revenue of $152 million

  May 15, 2018

   · 

  34 min read
• Business

  Alnylam Appoints Colleen Reitan to the Board of Directors

  Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the appointment of a veteran healthcare leader, Colleen Reitan, to Alnylam’s Board of Directors, effective June 1, 2018.

  May 15, 2018

   · 

  5 min read
• Business

  Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update

  TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track

  May 15, 2018

   · 

  6 min read
• BioCapital

  REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation

  The company recognizes International MPS Awareness Day 2018 on May 15 and supports the 5th Annual Million Dollar Bike Ride for rare disease research

  May 15, 2018

   · 

  8 min read
• Pharm Country

  PAVmed Announces Adjustment to Series Z Warrant Exercise Price

  The effective date of the exercise price reduction will be June 1, 2018.

  May 15, 2018

   · 

  3 min read
• Business

  ImmusanT Welcomes Ken Truitt, M.D. as Chief Medical Officer

  ImmusanT is a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy platform to translate and deliver first-in-class peptide-based immune therapies to patients living with autoimmune diseases

  May 15, 2018

   · 

  4 min read